Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2970872rdf:typepubmed:Citationlld:pubmed
pubmed-article:2970872lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C0002351lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C1136085lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:2970872lifeskim:mentionsumls-concept:C2003905lld:lifeskim
pubmed-article:2970872pubmed:issue3lld:pubmed
pubmed-article:2970872pubmed:dateCreated1988-10-19lld:pubmed
pubmed-article:2970872pubmed:abstractTextThe phenotypic pattern of peripheral blood T (PBT) lymphocytes was correlated with diagnosis and clinical status in 63 patients with monoclonal gammopathies (MGs). The numbers of lymphocytes expressing activation and CD11 determinants were significantly increased in suppressor/cytotoxic and helper/inducer subpopulations of patients with multiple myeloma (MM) and MG of undetermined significance (MGUS). The number of activated suppressor/cytotoxic cells was closely correlated with diagnosis and disease status. These cells were significantly higher in MM at diagnosis (160 +/- 88) than MGUS patients (61 +/- 79; P less than .01). Their number decreased to MGUS levels in MM in stable remission (58 +/- 53), but not in MM with tumor progression (172 +/- 102; P less than .001). In individual patients, part of these cells specifically adhered to dishes precoated with the related M-protein. No monoclonal T-beta gene rearrangement was detected in PBT and cytotoxic/suppressor subpopulations from two patients with a large proportion of activated cells.lld:pubmed
pubmed-article:2970872pubmed:languageenglld:pubmed
pubmed-article:2970872pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2970872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2970872pubmed:statusMEDLINElld:pubmed
pubmed-article:2970872pubmed:monthSeplld:pubmed
pubmed-article:2970872pubmed:issn0006-4971lld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:PileriAAlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:BoccadoroMMlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:BianchiAAlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:FossatiGGlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:PalumboAAlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:DianzaniUUlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:MassaiaMMlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:BattaglioSSlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:CamponiAAlld:pubmed
pubmed-article:2970872pubmed:authorpubmed-author:PioppoPPlld:pubmed
pubmed-article:2970872pubmed:issnTypePrintlld:pubmed
pubmed-article:2970872pubmed:volume72lld:pubmed
pubmed-article:2970872pubmed:ownerNLMlld:pubmed
pubmed-article:2970872pubmed:authorsCompleteYlld:pubmed
pubmed-article:2970872pubmed:pagination1064-8lld:pubmed
pubmed-article:2970872pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:meshHeadingpubmed-meshheading:2970872-...lld:pubmed
pubmed-article:2970872pubmed:year1988lld:pubmed
pubmed-article:2970872pubmed:articleTitleActivated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status.lld:pubmed
pubmed-article:2970872pubmed:affiliationDepartment of Medicine and Experimental Oncology, University of Torino, Italy.lld:pubmed
pubmed-article:2970872pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2970872pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2970872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2970872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2970872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2970872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2970872lld:pubmed